Norman Brito-Dellan, M.D.
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Program Director, Onco-Hospitalist Fellowship Program, Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 1994 | Central University of Venezuela, "Luis Razetti" School of Medicine, Caracas, VE, MD |
Postgraduate Training
| 2024-2024 | R25 Knowledge Synthesis Workshop: Systematic Reviews, Meta-Analyses, and Clinical Decision Making, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2023-2023 | Office of Online Learning, External Education. Certificate of Achievement, HMX Pro Immunology- Novel Therapies for Chronic Inflammation, Harvard Medical School, Houston, Texas |
| 2022-2022 | Office of Online Learning, External Education. Certificate of Achievement, HMX Pro Immunology- Immuno-oncology, Harvard Medical School, Cambridge, Massachusetts |
| 2020-2021 | Health Educators Fellowship Program, The University of Texas Health Science Center at Houston (UTHealth), Houston, Texas |
| 2010-2012 | Clinical Safety and Effectiveness Program, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2001-2002 | Hematology/Oncology- Palliative Medicine Fellowship Program, Hospice and Palliative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio |
| 1998-2001 | Categorical Internal Medicine Residency Program, Internal Medicine, University of Utah, Salt Lake City, Utah |
Licenses & Certifications
| 2025 | DEA |
| 2024 | BLS |
| 2024 | ACLS |
| 2011 | Texas Medical License |
| 2010 | American Board of Hospice and Palliative Medicine |
| 2001 | American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Associate Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2019 - 2025
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2019
Administrative Appointments/Responsibilities
Program Director, Oncologic Hospitalist Fellowship Program, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present
Program Director, Oncologic Hospitalist Fellowship Program, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020
Medical Director, Palliative Care Program, Dixie Regional Medical Center, St. George, UT, 2010 - 2011
Medical Director, Intermountain Home Care and Hospice, St. George, UT, 2007 - 2011
Medical Director, Zion's Way Hospice, St. George, UT, 2005 - 2006
Medical Director, Odyssey Hospice, St. George, UT, 2005 - 2006
Medical Director, Southwest Utah Public Health Department, St. George, UT, 2003 - 2006
Medical Director, Southwest Utah Community Health Center, St. George, UT, 2003 - 2006
Other Professional Positions
Hospitalist, Hospitalist, Dixie Regional Medical Center, Saint George, Utah, 2007 - 2011
Medical Director, Internal Medicine, Southwest Utah Community Health Center, Saint George, Utah, 2003 - 2006
Intramural Institutional Committee Activities
RME credit earned: 1 credit, Acute Hospital Management of Hypercalcemia Institutional Algorithm, The University of Texas MD Anderson Cancer Center, 2024
Extramural Institutional Committee Activities
Member, Acute Cancer Care Center (ACC)/Inpatient (IP) Integrated Care Pathway for the Initial Diagnosis and Management of Suspected Immune-Checkpoint Inhibitor (ICI)-Related Adverse Events (irAEs), The University of Texas MD Anderson Cancer Center, 2022
Member, DoIM Education Task Force, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, DoIM Toxicity Working Group, The University of Texas MD Anderson Cancer Center, 2019 - Present
Member, Transition to Hospice Working Group, The University of Texas MD Anderson Cancer Center, 2019 - Present
Graduate Medical Education (GME) Curriculum Subcommittee, Graduate Medical Education Committee (GMEC), The University of Texas MD Anderson Cancer Center, 2017 - Present
Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2016 - 2021
Member, PRS Retirement Board, The University of Texas MD Anderson Cancer Center, 2015 - 2019
Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2019
Honors & Awards
| 2025 | Winner, 2025 Education and Mentorship Advancement Award, MD Anderson Celebration of Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2025 | Winner, 2025 Excellence in Education Award, Division of Internal Medicine Employee & Faculty Excellence Awards, The University of Texas MD Anderson Cancer Center Division of Internal Medicine |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2024. Updates in Hospital Medicine. General Internal Medicine Clinical and Research Conference. Conference. Updates in Hospital Medicine. General Internal Medicine Clinical and Research Conference. Houston, TX, US.
- 2024. Emergent Management of Common Oncologic Emergencies. Graduate Medical Education (GME) Curriculum Subcommittee. Conference. Emergent Management of Common Oncologic Emergencies. Graduate Medical Education (GME) Curriculum Subcommittee. Houston, TX, US.
- 2023. Cytokine-release syndrome (CRS) after using an anti-PD-L1 and radiotherapy in a patient with cholangiocarcinoma: An unusual presentation at the Onco-Hospitalist Teaching Service. FY23 IOTOX Educational Lecture Series. Conference. Cytokine-release syndrome (CRS) after using an anti-PD-L1 and radiotherapy in a patient with cholangiocarcinoma: An unusual presentation at the Onco-Hospitalist Teaching Service. FY23 IOTOX Educational Lecture Series. Houston, TX, US.
National Presentations
- 2024. Session Chair: “E-Posters: Hemostasis + Neutropenia, Infection & Myelosuppression. Conference. MASCC 2024 Annual Meeting. Lille, FR.
- 2024. Cancer-Associated Thrombosis: Pioneering Strategies for Optimal Clinical Management of Thrombosis. Conference. MASCC 2024 Annual Meeting,. Lille, FR.
- 2023. “Cancer and the Immune System”: The use of medical animation to educate on immuno-oncology and immune-related adverse events. Conference. “Cancer and the Immune System”: The use of medical animation to educate on immuno-oncology and immune-related adverse events, US.
International Presentations
- 2025. Prevention and management of bleeding complications in cancer patients: best practices and innovations. Invited. Oral Bleeding and Hemostasis in Cancer Patients, US.
Formal Peers
- 2018. Handoffs and Physician Communication. Invited. Tyles, TX, US.
Selected Publications
Peer-Reviewed Articles
- Chan RJ, Knowles R, Ashbury FD, Bowen J, Chan A, Chin M, Olver I, Taylor C, Tinianov S, Alberti P, Bossi P, Brito-Dellan N, Cooksley T, Crawford GB, Dixit N, Fitch MI, Freedman JL, Ginex PK, Hart NH, Hertz DL, Jefford M, Koczwara B, Naito T, Orsey AD, Ruhlmann CH, Tsoukalas N, van den Hurk C, Van Sebille Y, Wardill HR, Scotte F, Lustberg M. Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study. EClinicalMedicine 76:102825, 2024. e-Pub 2024. PMID: 39309723.
- Brito-Dellan N, Franco-Vega MC, Ruiz JI, Lu M, Sahar H, Rajapakse P, Lin HY, Peterson C, Leal-Alviarez D, Altay H, Tomy S, Manzano JM. Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Support Care Cancer 32(10):661, 2024. e-Pub 2024. PMID: 39283351.
- Brito-Dellan N, Tsoukalas N, Font C. Thrombosis, cancer, and COVID-19. Support Care Cancer 30(10):8491-8500, 2022. e-Pub 2022. PMID: 35567609.
- Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J, Bektas Kayhan K, van de Wetering M, Brito-Dellan N, Kataoka T, Chiang K, Ranna V, Vaddi A, Epstein J, Lalla RV, Bossi P, Elad S, Oral Oncology MSGOTMAOSCICSO. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 28(5):2473-2484, 2020. e-Pub 2020. PMID: 32052137.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual 33(6):629-636, 2018. e-Pub 2018. PMID: 29779398.
Patient Reviews
CV information above last modified July 22, 2026